atorvastatin and semaglutide + Statins: Safety, Interactions & Lipid Monitoring – PlexusDx Ozempic for High Cholesterol: Evidence

Its mechanismactivating both GLP-1 and GIP receptorsnot only facilitates insulin release but also moderates food absorption, leading indirectly to weight loss when used in higher doses

doi: 10.1038/s41587-021-01024-0

FOR PERSONAL USE ONLY

Compared to insulin, GLP-1RA medications were associated with a significantly lower risk of liver cancer (HR: 0.47, 95% CI: 0.270.82) and pancreatic cancer (HR: 0.23, 95% CI: 0.110.51)

NOTA BENE Per conoscere con precisione gli effetti indesiderati e le controindicazioni di un dato medicinale a base di semaglutide, si raccomanda di leggerne con attenzione il foglietto illustrativo

In practice, providers often report multi-day delays for GLP-1 scripts